Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now…
Americans Need Relief from Big Pharma’s Out-of-Control Prescription Prices Morning Consult Lauren Aronson April 19, 2021 https://morningconsult.com/opinions/americans-need-relief-from-big-pharmas-ou…
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for…
Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on Oncology Medications THE PROBLEM: A CRISIS OF AFFORDABILITY The out-of-control prices set by Big Pharma on prescription…
PhRMA Proposals Fail to Lower Rx Prices and Instead Benefit Drug Companies and Shift Costs — While Ad Campaign Seeks to Divert Attention from Egregious Practices This week, the principal trade…
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Areas like Oncology, and the Urgency to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi…
Government Report Finds No Relationship Between Drug Company R&D and Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The…
Lawmakers Make Bipartisan Commitment to Lowering Drug Prices, Holding Drug Companies Accountable During a hearing on prescription drug prices on Tuesday before the U.S. Senate Committee on Health,…
Legislation Will Boost Transparency to Hold Big Pharma Accountable for Egregious Pricing Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C.
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The…